1. Home
  2. APM

as 05-24-2024 12:32pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Founded: N/A Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 26.0M IPO Year: 2018
Target Price: N/A AVG Volume (30 days): 2.5M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.62 EPS Growth: N/A
52 Week Low/High: $1.35 - $17.49 Next Earning Date: 06-04-2024
Revenue: $431,378 Revenue Growth: -72.02%
Revenue Growth (this year): 157729.1% Revenue Growth (next year): -78.44%

Share on Social Networks: